Skip to Main Content

Paper Details

Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer.
Cancer Discov
30
2020
2-OG, BBOX1, HER2, IP3R3, TNBC, TNBC cell, TNBC cells, Triple-Negative Breast Cancer, Triple-negative breast cancer, calcium, essential gene, gamma-butyrobetaine, gamma-butyrobetaine hydroxylase 1, inositol-1,4,5-trisphosphate, inositol-1,4,5-trisphosphate receptor type 3, mTORC1, normal breast cells, tumor
Author NameAffiliation
Cheng FanLineberger Comprehensive Cancer Center, University of North Carolina School of Medicine
Laura E HerringUniversity of North Carolina
Jason W LocasaleDuke University School of Medicine
Jeremy M SimonLineberger Comprehensive Cancer Center, University of North Carolina School of Medicine
Jeremy M SimonUniversity of North Carolina
Jeremy M SimonCarolina Institute for Developmental Disabilities, University of North Carolina
Charles M PerouLineberger Comprehensive Cancer Center, University of North Carolina School of Medicine
  • 1 - 7

Datasets

Release 1.2